UHB launches mRNA cancer vaccine trial for colorectal cancer
BHP founder-members University Hospitals Birmingham NHS Foundation Trust (UHB) has become the UK’s first site to launch the BioNTech Messenger RNA (mRNA) cancer vaccines trial which aims to recruit…
Incurable blood cancer trial finds new drug better than current treatments
Patients with an incurable blood cancer – polycythaemia vera (PV) – may respond better to a new drug compared to conventional best treatment, a new clinical trial has found.
The rare cancer resu…
Second city’s strategic health alliance welcomes mental health trust as new member
Birmingham Health Partners has underlined its commitment to delivering research that enhances health and wellbeing by welcoming Birmingham and Solihull Mental Health NHS Foundation Trust (BSMHFT) a…
‘Vein-on-a-chip’ could help scientists study blood clots without animal models
Blood clot researchers could benefit from a new device that mimics a human vein, replacing the need for animals for some studies.
The vein-on-a-chip model has been developed by scientists at BHP…
Drug combination could overcome tumour resistance in paediatric cancers
Children with some solid tumours may benefit from receiving a combination of inhibitor drugs, according to interim results of research presented at the American Association of Cancer Research’s Ann…
West Midlands Innovation Accelerator to Spark Growth and Innovation
The Universities of Birmingham and Aston – both BHP members – are to participate in the West Midlands Innovation Accelerator announced this week by the West Midlands Combined Authority.Designed to …